Human umbilical cord (UC) is a promising source of mesenchymal stem cells (MSCs). Apart
from their prominent advantages, such as a painless collection procedure and faster self …

The paper presents current evidence on the properties of human umbilical cord‐derived
mesenchymal stem cells, including origin, proliferative potential, plasticity, stability of …

The umbilical cord has become an increasingly used source of mesenchymal stromal cells
for preclinical and, more recently, clinical studies. Despite the increased activity, several …

Wharton's jelly (WJ) is a gelatinous tissue within the umbilical cord that contains
myofibroblast-like stromal cells. A unique cell population of WJ that has been suggested as …

The human umbilical cord (UC) and placenta are non-invasive, primitive and abundant
sources of mesenchymal stromal cells (MSCs) that have increasingly gained attention …

Mesenchymal stem cells (MSCs) from bone marrow, adult organs and fetuses face the
disadvantages of invasive isolation, limited cell numbers and ethical constraints while …

Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to
collect lifesaving Wharton's jelly derived mesenchymal stem cells (WJ‐MSC). Evidences that …

Progress in the understanding of the biology of perinatal tissues has contributed to the
breakthrough revelation of the therapeutic effects of perinatal derivatives (PnD), namely birth …

Umbilical cords as a source of stem cells are of increasing interest for cell therapies as they
present little ethical consideration and are reported to contain immune privileged cells which …

The human umbilical cord (UC) is an attractive source of mesenchymal stem cells (MSCs)
with unique advantages over other MSC sources. They have been isolated from different …